The DIA India Annual Meeting (IAM) 2026 marks a defining moment for India’s life sciences and healthcare ecosystem. As science, technology, and regulation converge at unprecedented speed, IAM 2026 emerges as the platform where future-ready strategies are shaped, tested, and translated into real-world impact.
Bringing together global and Indian leaders from pharma, biotech, medical devices, regulators, academia, and technology, IAM 2026 goes beyond dialogue-it enables decision-making, collaboration, and action across the full product lifecycle.
With six deep-dive tracks and two high-impact plenary sessions, this year’s meeting reflects the expanding scope and complexity of modern healthcare, from advanced therapies and digital innovation to regulatory transformation, patient safety, and evidence generation. IAM 2026 is designed for leaders who are not just adapting to change, but shaping what comes next.
Meet with Eurofins Central Laboratory to build relationships, discover new solutions, and exchange actionable insights to accelerate your clinical trial laboratory testing strategy.
We look forward connecting with you in Navi Mumbai!
We warmly invite you to schedule a meeting in advance with Amitavo Banerjee to discuss upcoming studies, operational challenges, and strategies to optimize laboratory execution within your overall clinical trial strategy.